The Effect of Open-Label Semaglutide on Metabolic Dysfunction-Associated Steatotic Liver Disease in People With HIV

Ann Intern Med. 2024 Apr 30. doi: 10.7326/M23-3354. Online ahead of print.NO ABSTRACTPMID:38684100 | DOI:10.7326/M23-3354

Source: Annals of Internal Medicine - April 29, 2024 Category: Internal Medicine Authors: Jordan E Lake Douglas W Kitch Amy Kantor Raja Muthupillai Karin L Klingman Christina Vernon Pablo F Belaunzaran-Zamudio Carl J Fichtenbaum Sonya Heath Hugo Perazzo Kathleen Corey Todd T Brown Alan Landay Fred Sattler Kristine M Erlandson Source Type: research